Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-02-11A Multi-centre, Double-blind, Placebo Controlled, Parallel Group, Proof of Concept Study to Evaluate the Efficacy, Safety and Tolerability of KRP203 in Subjects With Moderately Active Refractory Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2020-02-10A Phase II Open-Label Extension Study to Evaluate the Long-Term Safety of Etrolizumab in Patients With Moderate to Severe Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2020-02-05Ultrasound Guided Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection- a Double Blind Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2020-01-30A Randomized, Single-Blind Study to Assess Efficacy and Safety of Dosing Mesalazine 800 mg Tablets (Asacol®) at 2.4 g Once Daily Versus Divided Doses 3 Times Daily for 12 Months in Maintenance of Remission of Ulcerative Colitis.
-
CLINICAL_TRIALS study record update · 2020-01-28Telehealth Enhancement of Adherence to Medication in Pediatric Inflammatory Bowel Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-01-27Randomized, Double-blind, Double-dummy, Placebo-controlled, Phase III Clinical Trial on the Efficacy and Safety of a 48-weeks Treatment With Gastro-resistant Phosphatidylcholine (LT-02) Versus Placebo Versus Mesalamine for Maintenance of Remission in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2020-01-18Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis (ACE-UC)
-
CLINICAL_TRIALS study record update · 2020-01-18Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD
-
CLINICAL_TRIALS study record update · 2020-01-18A Double-blind, Randomized, Placebo-controlled, Single-center, Dose-finding, Pilot Study Evaluating the Efficacy of VSL#3® in the Maintenance of Clinical and Endoscopic Remission of Mild-to-moderate UC
-
CLINICAL_TRIALS study record update · 2020-01-18A Phase 3, Multicenter, Randomized, Double-blind Study to Determine the Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis, in Both Acute and Maintenance Phases
-
CLINICAL_TRIALS study record update · 2020-01-14A Phase 1b, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GB004 in Adult Subjects With Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2020-01-13A Phase III Double Blind, Multi-Center Placebo Controlled Maintenance Trial of HMPL-004 in Subjects With Mild to Moderate Ulcerative Colitis With Clinical Remission or Response From Induction Therapy. (NATRUL-4)
-
CLINICAL_TRIALS study record update · 2020-01-02A Phase III, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2019-12-19Fecal Microbiota Transplantation for the Treatment of Chronic Pouchitis
-
CLINICAL_TRIALS study record update · 2019-12-17A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Study of the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of HMPL004-6599 in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2019-12-10Metabolomic Markers of Fatigue in Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2019-12-06Evolution of Fatigue in Patients With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2019-12-06Monocentric, Prospective Interventional Study to Assess the Degree of Disease Activity With a Multispectral Optoacoustic Tomography (MSOT) Handheld Scanner in Patients With Crohn's Disease or Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2019-12-05Reduction in Length of Hospitalization in Patients With Acute Severe Ulcerative Colitis Treated With Rescue Therapy With Infliximab by the Use of Web-app Constant-Care. One Year Follow-up, Inclusive Colectomy Rate.
-
CLINICAL_TRIALS study record update · 2019-12-04The Mango Consumption Improves Biomarkers for Inflammation in Inflammatory Bowel Disease Patients
-
CLINICAL_TRIALS study record update · 2019-11-27A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2019-11-27A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2019-11-26Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
-
CLINICAL_TRIALS study record update · 2019-11-25A Multicenter, Randomized, Double-Blind, Actively-Controlled Trial to Evaluate the Safety and Efficacy of a New Tablet Formulation and Dosing Regimen of Balsalazide Disodium 3.3 g Bid Versus Mesalamine (5-ASA) as Asacol® 0.8 g Tid in Mildly to Moderately Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2019-11-25Phase 3 Study to Establish the Efficacy and Safety of a New Tablet Formulation and Dosing Regimen of Balsalazide Disodium Dosed Twice Daily in Achieving Clinical Improvement in Subjects With Mildly to Moderately Active Ulcerative Colitis After 8 Weeks of Therapy